Nov 2026· Medical Oncology· Vol 43· 0 citations· 37 references
Medicine
TL;DR
MRI-based HR may support preoperative LNM assessment in early-stage CC, with HR’+ CL representing a parsimonious candidate model for further evaluation.
The combined model, which integrates clinical information with both multiparameter DLCT features and radiomics scores, offers a clinically valuable tool for preoperative LNM prediction in GA patients.
Dongfang Wang, Yu Lin, Ze-Yang Lin et al.· Journal of imaging informati...· 0 citations
Background To determine the best-performing peritumoral boundary among tested distances and evaluate the predictive value of preoperative multiparametric MRI radiomics for axillary lymph node metastasis (ALNM) in breast cancer. Methods Clinical and imaging data of 273 patients from two centers were retrospectively anal...
Bin Chu, T. Zhan, Xing Liu et al.· International Journal of Gen...· 0 citations
Background and Objectives: Pancreatic ductal adenocarcinoma (PDAC) is spatially heterogeneous and may extend beyond the tumour margin visible on CT. We compared intratumoral habitat radiomics with whole-tumour and 1-, 3-, and 5-mm peritumoral radiomics for overall survival after resection. Materials and Methods: This s...
Xiao-An Liu, Jia-Xuan Zhu, Yang Qian et al.· Current Oncology· 0 citations
Background Pathological complete response (pCR) after neoadjuvant systemic therapy (NST) is an important surrogate endpoint for breast cancer prognosis. Reliable pretreatment prediction of pCR remains difficult, as conventional imaging underutilizes the peritumoral microenvironment, including immune infiltration, matri...
Background Tumor budding (TB) is a histopathological marker of tumor aggressiveness and an established prognostic factor in colorectal cancer. In rectal cancer, however, TB is usually assessed on biopsy or resection material, and a reliable result may not be available when preoperative management is being considered. P...
Peng Chen, Yan-Yan Zhou, Dan Wu et al.· Frontiers in Oncology· 0 citations
In this small cohort, gallium-68 fibroblast activation protein inhibitor PET/CT showed a higher observed specificity than contrast-enhanced CT for the detection of locoregional LN metastases in gynecologic SCC, with no false-negative cases observed.
K. Michalski, A. Kosmala, P. Kohnle et al.· Anticancer Research· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.